Machecourt J, Longère P, Fagret D, Vanzetto G, Wolf J E, Polidori C, Comet M, Denis B
Department of Cardiology, Clinique Cardiologique, Centre Hospitalier Universitaire, Grenoble, France.
J Am Coll Cardiol. 1994 Apr;23(5):1096-106. doi: 10.1016/0735-1097(94)90597-5.
This study was designed to assess the prognostic value of thallium-201 single-photon emission computed tomographic (thallium SPECT) perfusion imaging in patients evaluated for stable angina pectoris and to examine the relation, if any, between the presence and extent of myocardial defect and future fatal or nonfatal cardiovascular events (revascularization, secondary myocardial infarction).
Compared with planar scintigraphy, thallium SPECT enables better evaluation of the extent of myocardial perfusion defect. However, its prognostic value has not yet been studied in a large population of patients.
Between 1987 and 1989 we studied 3,193 patients. After exclusion of patients with unstable angina, myocardial infarction during the previous month or earlier revascularization, 1,926 patients were followed up for 33 +/- 10 (mean +/- SD) months after stress thallium SPECT imaging (performed after exercise in 1,121 patients or during dipyridamole infusion in 805 patients). Thallium SPECT imaging of the left ventricle was divided into six segments.
After normal thallium SPECT imaging (715 patients), the annual total and cardiovascular mortality rates were, respectively, 0.42%/year and 0.10%/year and were significantly higher after abnormal thallium SPECT imaging (respectively, 2.1%, relative risk 5, p = 0.012; 1.5%, relative risk 15, p < 0.0001 [log-rank test]). There was a significant relation between the number of abnormal segments and cardiovascular mortality during follow-up (p < 0.02) or the occurrence of nonfatal events (p < 0.001). The extent of defect on the initial scan provided the best SPECT variable for long-term prognosis. Thallium SPECT imaging provided additive prognostic information compared with other clinical variables (gender, previous myocardial infarction) and exercise electrocardiogram.
In patients with stable angina, normal thallium SPECT imaging indicates a low risk patient, and the extent of myocardial defect is an important prognostic predictive factor.
本研究旨在评估铊 - 201单光子发射计算机断层扫描(铊SPECT)灌注成像在稳定型心绞痛患者评估中的预后价值,并探讨心肌缺损的存在及范围与未来致命或非致命心血管事件(血运重建、继发性心肌梗死)之间的关系(如有)。
与平面闪烁扫描相比,铊SPECT能够更好地评估心肌灌注缺损的范围。然而,其在大量患者中的预后价值尚未得到研究。
在1987年至1989年间,我们研究了3193例患者。排除不稳定型心绞痛、前一个月内发生心肌梗死或早期血运重建的患者后,1926例患者在负荷铊SPECT成像(1121例患者运动后进行,805例患者双嘧达莫输注期间进行)后接受了33±10(平均±标准差)个月的随访。左心室铊SPECT成像分为六个节段。
铊SPECT成像正常(715例患者)后,年度总死亡率和心血管死亡率分别为0.42%/年和0.10%/年,铊SPECT成像异常后显著更高(分别为2.1%,相对风险5,p = 0.012;1.5%,相对风险15,p < 0.0001[对数秩检验])。随访期间异常节段数量与心血管死亡率(p < 0.02)或非致命事件的发生(p < 0.001)之间存在显著关系。初始扫描时缺损的范围为长期预后提供了最佳的SPECT变量。与其他临床变量(性别、既往心肌梗死)和运动心电图相比,铊SPECT成像提供了额外的预后信息。
在稳定型心绞痛患者中,铊SPECT成像正常表明患者风险较低,心肌缺损的范围是一个重要的预后预测因素。